Amy E. Herr - 03 Feb 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
03 Feb 2026
Net transactions value
-$1,034
Form type
4
Filing time
05 Feb 2026, 18:30:33 UTC
Previous filing
03 Nov 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Herr Amy E. Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney previously filed 05 Feb 2026 0002055523

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +38 +1.8% $0.000000 2,192 03 Feb 2026 By significant other
transaction TECH Common Stock Tax liability $1,034 -16 -0.73% $64.63 2,176 03 Feb 2026 By significant other
holding TECH Common Stock 2,680 03 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -38 -33% $0.000000 77 03 Feb 2026 Common Stock 38 By significant other F7, F10
holding TECH Stock Option (Right to Buy) 2,415 03 Feb 2026 Common Stock 2,415 $72.05 Direct
holding TECH Stock Option (Right to Buy) 3,777 03 Feb 2026 Common Stock 3,777 $60.96 Direct F1
holding TECH Stock Option (Right to Buy) 6,636 03 Feb 2026 Common Stock 6,636 $47.60 By significant other F2
holding TECH Stock Option (Right to Buy) 4,472 03 Feb 2026 Common Stock 4,472 $66.97 By significant other F2
holding TECH Stock Option (Right to Buy) 2,076 03 Feb 2026 Common Stock 2,076 $120.46 By significant other F2
holding TECH Stock Option (Right to Buy) 2,104 03 Feb 2026 Common Stock 2,104 $94.52 By significant other F3
holding TECH Stock Option (Right to Buy) 1,084 03 Feb 2026 Common Stock 1,084 $84.61 By significant other F4
holding TECH Stock Option (Right to Buy) 1,468 03 Feb 2026 Common Stock 1,468 $74.91 By significant other F5
holding TECH Stock Option (Right to Buy) 344 03 Feb 2026 Common Stock 344 $72.05 By significant other F6
holding TECH Restricted Stock Units 118 03 Feb 2026 Common Stock 118 By significant other F7, F8
holding TECH Restricted Stock Units 320 03 Feb 2026 Common Stock 320 By significant other F7, F9
holding TECH Restricted Stock Units 932 03 Feb 2026 Common Stock 932 By significant other F7, F11
holding TECH Stock Option (Right to Buy) 2,735 03 Feb 2026 Common Stock 2,735 $53.60 By significant other F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
F2 Fully vested.
F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F8 118 restricted stock units vest on 8/15/2026.
F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
F10 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.